BackPURE Bioscience Overview

PURE Bioscience Total Current Liabilities

Track PURE Bioscience's total current liabilities ($3.7M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$3.65M
275.93% YoYΔ $2.68M vs prior year quarter

Peer average

Loading

PURE Bioscience Total Current Liabilities History

Loading

PURE Bioscience vs. peers: Total Current Liabilities Comparison

Loading

PURE Bioscience Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

PURE Bioscience (PURE) FAQ

As of the most recent data (April 2026), PURE shows a total current liabilities of $3.7M. That compares with $970K in the prior-year period — up 275.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PURE's total current liabilities is now $3.7M (was $970K) — a 275.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether PURE Bioscience is outperforming or lagging.

Tracking PURE's total current liabilities over time shows whether PURE Bioscience is scaling, shrinking, or reshaping that part of the business. The current reading is $3.7M That compares with $970K in the prior-year period — up 275.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has PURE Bioscience's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $3.7M) with ownership activity and broader fundamentals.